Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Carlyle and CVC have struck arrangements to share portions of performance fees with UBS in return for the bank distributing their private capital products to affluent clients. Carlyle’s deal involves carried interest from an evergreen secondaries fund, while CVC agreed to allow UBS to share performance fees in an evergreen fund. At least two other …
Global markets traded unevenly on Friday as the Middle East conflict intensified, sending energy prices sharply higher and unsettling shipping and air travel. U.S. and European futures gained while Asian equities pared losses. Concerns about renewed inflation pushed yields up and prompted investors to price in more hawkish central bank stances. Att…
Most Asian currencies firmed slightly on Friday as the U.S. dollar eased modestly after a prior run-up, yet the region remains poised for weekly losses. Escalating hostilities involving Iran, Israel and the United States have pushed oil prices sharply higher this week, heightening concerns over energy supply disruptions and reigniting inflation and…
Australia's S&P/ASX 200 closed down 1.00% on Friday, pushed lower by losses in the Gold, Metals & Mining and Materials sectors. Market breadth favored decliners, the benchmark's implied-volatility gauge rose, and key commodity and currency contracts moved unevenly. The session saw several individual large movers on both the upside and downside…
A U.S. Court of International Trade judge will meet in a closed-door settlement conference with government attorneys to determine how to refund as much as $175 billion in tariffs the Supreme Court recently invalidated. The meeting centers on creating a practical mechanism for reimbursing more than 300,000 importers, a task the government says may r…
A director of Hercules Capital, Inc. (NASDAQ:HTGC) purchased 3,050 shares on March 4, 2026, for $14.78 each, a transaction that raised the director's direct holding to 19,560 shares. The filing shows the purchase was executed through the dividend reinvestment plan and was signed by an attorney-in-fact on March 5, 2026. The transaction comes amid co…
Huang Yiping, a member of the People’s Bank of China monetary policy committee, told Bloomberg TV that Beijing’s shift toward greater consumer-driven growth will be a gradual process. He warned investors not to expect heavy-handed stimulus, noting the government does not view the current situation as a crisis. China has set a 2026 growth target of …
ResMed director Peter C. Farrell sold 2,000 shares on March 4, 2026, for $260.22 per share, totaling $520,440. The transaction occurred under a Rule 10b5-1 plan adopted August 12, 2025. ResMed reported fiscal second-quarter 2026 earnings per share of $2.81, ahead of the $2.73 analyst estimate, while revenue of $1.4 billion matched forecasts. Severa…
Economists expect U.S. job growth to ease in February, with the unemployment rate projected to remain at 4.3%. Forecasters point to a normalization in healthcare hiring after an outsized January increase, potential drag from weather and regional strike action, and new Census-driven population controls that will revise labor force estimates. Rising …
Healthcare Realty Trust Executive Vice President and CFO Daniel Gabbay purchased 10 shares of common stock on March 4, 2026, at $18.74 per share for a total of $187. The transaction leaves him with 191,158 directly held shares and 10 indirectly held shares through a child. The company reported fourth-quarter 2025 results that beat EPS expectations …
Peter Doyle, co-portfolio manager of RENN Fund, Inc. (RCG), purchased 200 shares on March 4, 2026, at $2.92 per share for a total of $584. The transaction leaves Doyle with 900 shares held directly and an additional 13,334 shares held indirectly through a spouse. The fund is trading close to a 52-week high and shows recent gains and a low P/E by th…
Esam Elashmawi, Senior Vice President of Marketing and Strategy at Lattice Semiconductor, sold 38,000 shares on March 4, 2026, under a prearranged 10b5-1 trading plan adopted December 3, 2025. The dispositions generated $3,494,319 in proceeds. The transactions occurred across multiple price points and left Elashmawi with 161,192 shares directly hel…
SoftBank Group is pursuing a short-term loan facility of up to $40 billion, mainly to fund its investment in OpenAI. The proposed bridge loan, reportedly to be underwritten by a small group of banks including JPMorgan Chase, would carry a roughly 12-month tenor. The effort highlights SoftBank founder Masayoshi Son’s push to position the group at th…
The onshore yuan edged up late on March 6 but was poised to break a 13-week winning streak as a firmer dollar, linked to the widening Middle East conflict, and a policy shift on forward contracts increased corporate dollar demand. Policymaker remarks at the annual parliament session and China’s 2026 growth target will be watched for guidance.
The ongoing U.S.-Israel conflict with Iran, now in its seventh day, has forced shipping along the Strait of Hormuz to slow or stop, raising immediate risks for Asian automakers that send substantial volumes and value of vehicles to the Middle East. Manufacturers from China, India, South Korea and Japan ship billions of dollars' worth of cars to Gul…
Hercules Capital Chief Operating Officer Christian Follmann bought 5,000 shares on March 4, 2026, spending $73,400 at an average price of $14.68. The purchase increases his direct stake to 150,135 shares. The company shows a rising NAV estimate and offers a high dividend yield, while analysts and a short seller flagged software exposure and dividen…
Tarsus Pharmaceuticals Chief Operating Officer Neervannan Seshadri disposed of 8,366 shares on March 4, 2026, realizing $641,421 at $76.67 per share. The transaction was made under a Rule 10b5-1 trading plan adopted last November. The move coincides with recent quarterly results showing substantial product-driven revenue growth, while the stock tra…
Jason D. Phillips, Chief Accounting Officer & Controller at Moody’s Corporation, sold 333.123 shares of common stock on March 4, 2026, generating $157,437 in proceeds. Following the sale Phillips retains 2,097.9505 shares. Moody’s reported fourth-quarter results that exceeded expectations, driven by its ratings and analytics businesses, prompting a…
Asian equities were mixed on Friday but headed for pronounced weekly drops as an intensifying Middle East conflict and a surge in oil prices dampened investor sentiment. South Korea's KOSPI faced its steepest weekly fall, while other major Asian indexes also moved toward notable weekly declines amid concerns about energy supply disruption, inflatio…
Eric D. Chewning, executive vice president at Huntington Ingalls Industries, disposed of 1,700 shares on March 4, 2026, for $736,848. The transaction was reported in a Form 4 filing with the SEC. The sale comes as HII shares have risen 121% over the last year and after the company posted better-than-expected fourth-quarter 2025 results and drew rev…
The conflict that began a week ago has broadened to include multiple states and theaters. U.S. President Donald Trump publicly encouraged Iranian Kurdish forces based in Iraqi Kurdistan to consider attacks across the Iran border, while Azerbaijan said it would respond after being struck by drones. Israel reported a broad campaign against infrastruc…
Torran B. Nixon, Senior Executive Vice President at Columbia Banking System, INC. (NASDAQ: COLB), sold a total of 4,481 shares on March 3 and March 4, 2026, under a pre-established 10B5-1 trading plan. The transactions totaled $127,932. Columbia Banking trades near $28, carries a P/E of 12.13, and yields 5.29%, while several analysts raised price t…
Andrew Callos, Executive Vice President and Chief Commercial Officer at Cytokinetics (CYTK), sold 26,000 shares on March 5, 2026, for roughly $1.6 million and exercised options to acquire 26,000 additional shares the same day. The transactions leave Callos with 50,440 shares directly held. Analysts maintain optimistic price targets even as the comp…
United Therapeutics director Christopher Causey sold 20 shares of UTHR on March 4, 2026, for $9,803 and simultaneously exercised options to buy 20 shares at $119.76. The transactions were executed under a pre-arranged Rule 10b5-1 plan. The stock is trading near its InvestingPro Fair Value after a 58% year-over-year gain. Several analysts have raise…
Mastercard's shares have pulled back from last summer's highs and are trading at a valuation that, while not cheap, now embeds a reasonable margin of safety given $17.2B in free cash flow, a $467.6B market cap and a P/E near 31x. This trade idea lays out an actionable long with entry, stop and target for a mid-term (45 trading days) swing, explains…
